US Banks Denied Capital Relief as Fed Freezes Stress Test Buffers

Key facts

• The Federal Reserve has frozen stress capital buffers (SCBs) for U.S. banks.
• The freeze on SCBs will remain in effect until 2027.
• Analysis of the 2026 DFAST showed 23 of 30 firms had lower CET1 capital depletion.
• The freeze prevents lower stress test losses from translating into capital relief.
• This decision impacts the capital planning of major U.S. banks.

U.S. banks will not receive potential capital relief stemming from lower stress test losses due to the Federal Reserve's decision to freeze stress capital buffers (SCBs) until 2027. The Fed's action means that even though many banks demonstrated improved resilience in the 2026 Dodd-Frank Act Stress Tests (DFAST), the anticipated reduction in their capital requirements will not materialize.

Analysis of the 2026 DFAST results revealed that 23 out of the 30 firms evaluated would have seen a decrease in their Common Equity Tier 1 (CET1) capital depletion under the stress scenarios. This reduction in capital depletion is typically a precursor to a lower SCB, which in turn would free up capital for banks to use for dividends, share buybacks, or other investments. However, the Federal Reserve's decision to maintain the current SCB levels effectively nullifies this potential capital relief for the banks involved.